Justin Saeks and Bruce Carlson[email protected]InfectiousAntigen tests drive COVID-19 test market to $10.5BEven in the fall of 2020, there are capacity limitations, questions about testing accuracy, and challenges with sample collection. But creative solutions have been emerging at labs to help ease the load during a difficult time.November 9, 2020Page 1 of 1Top StoriesLawsuitU.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuitThe Patents Court of the High Court of England and Wales has ruled that two patents owned by Bio-Techne are invalid, rejecting a patent infringement lawsuit filed by Bio-Techne/ACD in the U.K. against Molecular Instruments.Point-of-Care TestingScout secures CARB-X grant to advance diagnostic test developmentSequencingMission Bio launches new features for Tapestri platformAlzheimer'sQuest adds new biomarker test to Alzheimer's portfolioSponsor ContentVisit our Molecular Diagnostics Community
